Chondroitin 6-sulfate and dextran sulfate promote hypochlorite-induced peroxidation of phosphatidylcholine liposomes

Chemistry and Physics of Lipids

Volumn 140, Issue 1-2, 2006, Pages 18-27

  Vakhrusheva, Tatyana ^a   Panasenko, Oleg ^a  

^a FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY   (Russian Federation)

Author keywords

Chondroitin sulfate; Dextran sulfate; Hypochlorous acid; Liposomes; Peroxidation

Indexed keywords

BUFFER; CALCIUM ION; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; DEXTRAN; DEXTRAN SULFATE; HYPOCHLORITE; HYPOCHLOROUS ACID; LIPOSOME; PHOSPHATE; PHOSPHATIDYLCHOLINE; REAGENT; SODIUM CHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADDITION REACTION; ARTICLE; ATHEROGENESIS; ELECTRICITY; EXPOSURE; FUNCTIONAL ASSESSMENT; INCUBATION TIME; LIPID PEROXIDATION; MODULATION; MOLECULAR MECHANICS; OXIDATION; PH; PRIORITY JOURNAL; SULFATION; SURFACE PROPERTY;

CALCIUM; CHEMISTRY, PHYSICAL; CHONDROITIN SULFATES; DEXTRAN SULFATE; HYPOCHLOROUS ACID; LIPID PEROXIDATION; LIPOSOMES; PHOSPHATIDYLCHOLINES;

EID: 33645857962     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2006.01.002     Document Type: Article

References (48)

1. Abuja P.M. Aggregation of LDL with chondroitin-4-sulfate makes LDL oxidizable in the presence of water-soluble antioxidants. FEBS Lett. 512 (2002) 245-248
2. Adams C.W., and Bayliss O.B. Acid mucosubstances underlying lipid deposits in ageing tendons and atherosclerotic arteries. Atherosclerosis 18 (1973) 191-195
3. Albertini R., Rindi S., Passi A., Bardoni A., Salvini R., Pallavicini G., and De Luca G. The effect of cornea proteoglycans on liposome peroxidation. Arch. Biochem. Biophys. 327 (1996) 209-214
4. 2+-mediated oxidation of liposomes. FEBS Lett. 383 (1996) 155-158
5. 2+-mediated LDL oxidation. FEBS Lett. 403 (1997) 154-158
6. Albertini R., De Luca G., Passi A., Moratti R., and Abuja P.M. Chodroitin-4-sulfate protects high-density lipoprotein against copper-dependent oxidation. Arch. Biochem. Biophys. 365 (1999) 143-149
7. Arnold K., Ohki S., and Krumbiegel M. Interaction of dextran sulfate with phospholipid surfaces and liposome aggregation and fusion. Chem. Phys. Lipids 55 (1990) 301-307
8. Berliner J.A., and Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20 (1996) 707-727
9. Camejo G., Hurt E., and Romano M. Properties of lipoprotein complexes isolated by affinity chromatography from human aorta. Biomed. Biochim. Acta 44 (1985) 389-401
10. Camejo G., Hurt-Camejo E., Rosengren B., Wiklund O., Lopez F., and Bondjers G. Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans. J. Lipid Res. 32 (1991) 1983-1991
11. Cardoso L.E., and Mourao P.A. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler. Thromb. 14 (1994) 115-124
12. Carr A.C., Myzak M.C., Stocker R., McCall M.R., and Frei B. Myeloperoxidase binds to low-density lipoprotein: potential importance for atherosclerosis. FEBS Lett. 487 (2000) 176-180
13. Daphna E.M., Michaela S., Eynat P., Irit A., and Rimon S. Association of myeloperoxidase with heparin: oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme. Mol. Cell Biochem. 183 (1998) 55-61
14. Daugherty A., Dunn J.L., Rateri D.L., and Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94 (1998) 437-444
15. Hawkins C.L., and Davies M.J. Degradation of hyaluronic acid, poly- and mono-saccharides, and model compounds by hypochlorite: evidence for radical intermediates and fragmentation. Free Radic. Biol. Med. 24 (1998) 1396-1410
16. Hazell L.J., Arnold L., Flowers D., Waeg G., Malle E., and Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97 (1996) 1535-1544
17. Hazen S.L., and Heinecke J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99 (1997) 2075-2081
18. Hurt-Camejo E., Camejo G., Rosengren B., Lopez F., Ahlstrom C., Fager G., and Bondjers G. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler. Thromb. 12 (1992) 569-583
19. Hurt-Camejo E., Olsson U., Wiklund O., Bondjers G., and Camejo G. Cellular consequences of the association of apoB lipoproteins with proteoglycans. Potential contribution to atherogenesis. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 1011-1017
20. 2H nuclear magnetic resonance. Biophys. J. 75 (1998) 909-916
21. Huster D., Paasche G., Dietrich U., Zschörnig O., Gutberlet T., Gawrisch K., and Arnold K. Investigation of phospholipid area compression induced by calcium-mediated dextran sulfate interaction. Biophys. J. 77 (1999) 879-887
22. Kim Y.C., and Nishida T. Nature of interaction of dextran sulfate with lecithin dispersions and lysolecithin micelles. J. Biol. Chem. 252 (1977) 1243-1249
23. 2+. J. Biol. Chem. 254 (1979) 9621-9626
24. Krumbiegel M., and Arnold K. Microelectrophoresis studies of the binding of glycosaminoglycans to phosphatidylcholine liposomes. Chem. Phys. Lipids 54 (1990) 1-7
25. Krumbiegel M., Zschoernig O., Arnold K., Panasenko O., Volnova T., Azizova O.A., Deev A.I., and Herrmann K. Interaction of glycosaminoglycans with low density lipoproteins and liposomes detected by alterations of surface potential. Chem. Phys. Lipids 48 (1988) 83-89
26. 2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur. J. Biochem. 267 (2000) 4495-4503
27. Mitsuya H., Looney D.J., Kuno S., Ueno R., Wong-Staal F., and Broder S. Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells. Science 240 (1988) 646-649
28. Morris J.C. The acid ionization constant of HOCl from 5 °C to 35 °C. J. Phys. Chem. 70 (1966) 3798-3805
29. Mourao P.A., Pillai S., and Di Ferante N. The binding of chondroitin 6-sulfare to plasma low density lipoprotein. Biochim. Biophys. Acta 674 (1981) 178-187
30. Navab M., Ananthramaiah G.M., Srinivasa T.R., Van Lenten B.J., Ansell B.J., Gregg C.F., Vahabzadeh K., Hama S., Hough G., Kamranpour N., Berliner J.A., Lusis A.J., and Fogelman A.M. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J. Lipid Res. 45 (2004) 993-1007
31. Panasenko O.M., Arnhold J., Schiler J., Arnold K., and Sergienko V.I. Peroxidation of egg yolk phosphatidylcholine liposomes by hypochlorous acid. Biochim. Biophys. Acta 1215 (1994) 259-266
32. Panasenko O.M., Arnhold J., Vladimirov Yu.A., Arnold K., and Sergienko V.I. Hypochlorite-induced peroxidation of egg yolk phosphatidylcholine is mediated by hydroperoxides. Free Radic. Res. 27 (1997) 1-12
33. Pero R.W., Sheng Y., Olsson A., Bryngelsson C., and Lund-Pero M. Hypochlorous acid/N-chloramines are naturally produced DNA repair inhibitors. Carcinogenesis 17 (1996) 13-18
34. Rice-Evans C., Leake D., Bruckdorfer K.R., and Diplock A.J. Practical approaches to low density lipoprotein oxidation: whys, wherefores and pitfalls. Free Radic. Res. 25 (1996) 285-311
35. She Z.W., Liming J.D., Fagan J.B., Pacht E.R., and Davis W.B. Inhibition of hypochlorous acid by lidocaine and native components of alveolar epithelial lining fluid. Am. Rev. Respir. Dis. 144 (1991) 227-230
36. Skipski V.P. Lipid composition of lipoproteins in normal and diseased states. In: Nelson G.J. (Ed). Blood Lipids and Lipoproteins: Quantitation, Composition, and Metabolism (1972), Wiley-Interscience, New York 471-483
37. Small D.M., and Shipley G.G. Physical-chemical basis of lipid deposition in atherosclerosis. Science 185 (1974) 222-229
38. Steffan G., Wulff S., and Galla H.-J. Divalent cation-dependent interaction of sulfated polysaccharides with phophatidylcholine and mixed phosphatidylcholine/phosphatidylglycerol liposomes. Chem. Phys. Lipids 74 (1994) 141-150
39. Theocharis A.D., Theocharis D.A., De Luca G., Hjerpe A., and Karamanos N.K. Compositional and structural alterations of chondroitin and dermatan sulfates during the progression of atherosclerosis and aneurysmal dilatation of the human abdominal aorta. Biochimie 84 (2002) 667-674
40. Toledo O.M., and Mourao P.A. Sulfated glycosaminoglycans of human aorta: chondroitin 6-sulfate increase with age. Biochem. Biophys. Res. Commun. 89 (1979) 50-55
41. Volker W., Schmidt A., Oortmann W., Broszey T., Faber V., and Buddecke E. Mapping of proteoglycans in atherosclerotic lesions. Eur. Heart J. 11 Suppl. E (1990) 29-40
42. 2+- and AAPH-mediated oxidation of human low-density lipoproteins depends on glycosaminoglycan structure. Biochimie 81 (1999) 955-963
43. 2+-mediated oxidation of human low-density lipoproteins: effect of normal human plasma-derived chondroitin sulfate. J. Biochem. (Tokyo) 125 (1999) 297-304
44. Voszka I., Gyorgyi S., and Bihari-Varga M. Effect of glycosaminoglycans and divalent cations on the thermal properties of dipalmitoylphosphatidylcholine. Chem. Phys. Lipids 51 (1989) 67-71
45. Wiklund O., Björnheden T., Olofsson S.-O., and Bondjers G. Influx and cellular degradation of low density lipoproteins in rabbit aorta determined in an in vitro perfusion system. Arteriosclerosis 7 (1987) 565-571
46. Williams K.J., and Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 551-561
47. Willis E.D. Lipid peroxide formation in microsomes. General considerations. Biochem. J. 113 (1969) 315-324
48. Yang F., Zhao P., Zhang Y., Han X., Yang R., Liang F., Wu Y., Zhao H., and Zhang Z. Relationship between chondroitin sulfate proteoglycan and coronary atherosclerosis in the youth. Chin. Med. J. 109 (1996) 162-167